Biotechnology Group, Chemical Engineering Department, Tarbiat Modares University, P.O. Box 14115-143, Tehran, Iran.
Biotechnol Appl Biochem. 2010 Apr 14;55(4):209-14. doi: 10.1042/BA20090256.
The expression of rhIL-2 (recombinant human interleukin-2) in bacteria results in the formation of insoluble inclusion-body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2-mercaptoethanol) and then purified using IMAC (immobilized metal-ion-affinity chromatography). IMAC was used to capture rhIL-2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL-2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin-2.
rhIL-2(重组人白细胞介素-2)在细菌中的表达导致不溶性包涵体聚集物的形成。这些聚集物首先在变性条件下(含 8 M 尿素和 10 mM 2-巯基乙醇的磷酸钠缓冲溶液)溶解,然后使用 IMAC(固定化金属离子亲和层析)进行纯化。IMAC 用于捕获 rhIL-2。在存在 10%(v/v)甘油的情况下,通过梯度洗脱(从 8 M 到 0 M 尿素),在柱上逐渐复性蛋白质。甘油用于防止复性步骤中的蛋白质聚集。使用这种方法,rhIL-2 的纯度达到 97%,并通过淋巴细胞转化试验测量其活性。测量的活性与商业人白细胞介素-2相同。